Patent details

Basic Information

Publication number:

EP2327698

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100100486

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate

French Title of Invention:

Méthode pour préparer l'hemihydrate de l'hydrochlorure de (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

German Title of Invention:

Verfahren zur Herstellung des (R)-8-Chlor-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinhydrochlorid-Hemihydrat

SPC Number:

Dates

Filing date:

20/12/2005

Grant date:

05/08/2015

EP Publication Date:

05/08/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/06/2011

EP B1 Publication Date:

05/08/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/12/2015

Expiration date:

20/12/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2005

 

 

Name:

Arena Pharmaceuticals Inc.

Address:

6154 Nancy Ridge Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:

Betts III William L.

Address:

United States (US)

2

Name:

Post Noah

Address:

United States (US)

3

Name:

Agarwal Rajesh Kumar

Address:

United States (US)

4

Name:

Kiang Yuan-Hon

Address:

United States (US)

5

Name:

Henshilwood James A.

Address:

United States (US)

Priority

Priority Number:

638221 P

Priority Date:

21/12/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 223/16;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages